Home Cart 0 Sign in  
X

[ CAS No. 79-14-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 79-14-1
Chemical Structure| 79-14-1
Chemical Structure| 79-14-1
Structure of 79-14-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 79-14-1 ]

Related Doc. of [ 79-14-1 ]

Alternatived Products of [ 79-14-1 ]

Product Details of [ 79-14-1 ]

CAS No. :79-14-1 MDL No. :MFCD00004312
Formula : C2H4O3 Boiling Point : -
Linear Structure Formula :- InChI Key :AEMRFAOFKBGASW-UHFFFAOYSA-N
M.W : 76.05 Pubchem ID :757
Synonyms :
Hydroxyethanoic acid;dicarbonous acid;Glycollic acid;hydroacetic acid;hydroxyacetic acid

Calculated chemistry of [ 79-14-1 ]

Physicochemical Properties

Num. heavy atoms : 5
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.5
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 14.66
TPSA : 57.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.55 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.24
Log Po/w (XLOGP3) : -1.11
Log Po/w (WLOGP) : -0.94
Log Po/w (MLOGP) : -1.37
Log Po/w (SILICOS-IT) : -0.81
Consensus Log Po/w : -0.8

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : 0.45
Solubility : 216.0 mg/ml ; 2.84 mol/l
Class : Highly soluble
Log S (Ali) : 0.39
Solubility : 188.0 mg/ml ; 2.47 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : 1.04
Solubility : 844.0 mg/ml ; 11.1 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 79-14-1 ]

Signal Word:Danger Class:8
Precautionary Statements:P264-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P403+P233-P501 UN#:3261
Hazard Statements:H314-H332 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 79-14-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 79-14-1 ]
  • Downstream synthetic route of [ 79-14-1 ]

[ 79-14-1 ] Synthesis Path-Upstream   1~33

  • 1
  • [ 79-14-1 ]
  • [ 496-72-0 ]
  • [ 20034-02-0 ]
YieldReaction ConditionsOperation in experiment
100% With hydrogenchloride In water for 3 h; Reflux (5-Methyl-1H-benzimidazole-2-yl)-methanol 25 was prepared using the Phillips procedure [1], 4-Methyl-1,2-phenylenediamine (12.22 g; 0.1 mol) and glycolic acid (11.40 g; 0.15 mmol) in hydrochloric acid (50 ml, 5.5 M) were heated under reflux with for 3 h. The reaction mixture was cooled to room temperature and ammonia solution was added and the mixture cooled in ice until a bright brown precipitate formed. The resulting solid was recrystallised from aqueous ethanol to give (5-methyl-1H-benzimidazole-2-yl)-methanol as a pale creamy powdery solid Yield 100percent.
72% at 130℃; for 3 h; General procedure: To a mixture of 1a–1c (10 mmol) with glycolic acid (2.28 g, 30 mmol) was added concentrated H3PO4(20 mL). The reaction mixture was refluxed at 130°C for 3 h, then quenched with 20percent NaOH. The respective solid product was collected by filtration.
70% at 150℃; for 3 h; Step 1
The mixture of 4-methyl-benzene-1,2-diamine (500 mg, 4.10 mmol) and hydroxy-acetic acid (374 mg, 4.92 mmol) was heated to 150° C. with stirring for 3 hrs.
After cooled to room temperature, the reactant was purified by silica gel column (DCM/MeOH=30/1) to afford (5-methyl-1H-benzoimidazol-2-yl)-methanol (400 mg, yield: 70percent) as a yellow solid.
Reference: [1] Molecules, 2015, vol. 20, # 8, p. 15206 - 15223
[2] Bulletin of the Korean Chemical Society, 2013, vol. 34, # 4, p. 1272 - 1274
[3] Russian Journal of General Chemistry, 2017, vol. 87, # 12, p. 3006 - 3016
[4] Patent: US2018/44324, 2018, A1, . Location in patent: Paragraph 0614
[5] Chemische Berichte, 1912, vol. 45, p. 3495
[6] Journal of the American Chemical Society, 1957, vol. 79, p. 4391,4393
[7] Journal of the Chemical Society, 1950, p. 1600,1602
[8] Biochemische Zeitschrift, 1955, vol. 327, p. 422,447
[9] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 933 - 936
[10] European Journal of Medicinal Chemistry, 2016, vol. 122, p. 584 - 600
  • 2
  • [ 79-14-1 ]
  • [ 95-83-0 ]
  • [ 6953-65-7 ]
YieldReaction ConditionsOperation in experiment
82% at 150℃; for 4 h; 21 a)A mixture of 4-chlorobenzene-1,2-diamine (105 g, 736 mmoles, 1 eq.) andhydroxyacetic acid (112 g, 2 eq.) in xylene (1500 mL) was stirred at 150 °C for 4 hours. The mixture was then cooled to 60 °C and treated with 3N HC1 (480 ml), then basified to pH=7-8 by the addition of aqueous ammonia. The mixture was filtered and the solid was collected, washed with H20 and tert-butyl methyl ether to give 123 g (82percent yield) of (5 -chloro- 1 H-benzo [d]imidazo l-2-yl)methano 1 21 a.
82% at 150℃; for 4 h; A mixture of 4-chlorobenzene-1,2-diamine (105 g, 736 mmoles, 1 eq.) and hydroxyacetic acid (112 g, 2 eq.) in xylene (1500 mL) was stirred at 150°C for 4 hours. The mixture was then cooled to 60°C and treated with 3N HC1 (480 ml), then basified to pH = 7-8 by the addition of aqueous ammonia. The mixture was filtered and the solid was collected, washed with H20 and tert-butyl methyl ether to give 123 g (82percent yield) of (5 -chloro- 1 H-benzo [d]imidazol-2-yl)methanol (7a).
Reference: [1] Molecules, 2015, vol. 20, # 8, p. 15206 - 15223
[2] Patent: WO2014/60411, 2014, A1, . Location in patent: Page/Page column 58
[3] Patent: WO2015/158653, 2015, A1, . Location in patent: Page/Page column 37; 38
[4] Annales Pharmaceutiques Francaises, 2003, vol. 61, # 1, p. 57 - 61
[5] Bulletin of the Korean Chemical Society, 2013, vol. 34, # 4, p. 1272 - 1274
[6] Chemische Berichte, 1951, vol. 84, p. 719,727
[7] Journal of the Chemical Society, 1949, p. 1260,1268
[8] Journal of the Chemical Society, 1950, p. 1515,1516
[9] Patent: WO2004/22060, 2004, A2, . Location in patent: Page/Page column 24
[10] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 933 - 936
[11] MedChemComm, 2018, vol. 9, # 7, p. 1194 - 1205
  • 3
  • [ 79-14-1 ]
  • [ 99-56-9 ]
  • [ 20034-00-8 ]
YieldReaction ConditionsOperation in experiment
87% at 130℃; for 3 h; General procedure: To a mixture of 1a–1c (10 mmol) with glycolic acid (2.28 g, 30 mmol) was added concentrated H3PO4(20 mL). The reaction mixture was refluxed at 130°C for 3 h, then quenched with 20percent NaOH. The respective solid product was collected by filtration.
Reference: [1] Russian Journal of General Chemistry, 2017, vol. 87, # 12, p. 3006 - 3016
[2] Bulletin of the Korean Chemical Society, 2013, vol. 34, # 4, p. 1272 - 1274
[3] Molecules, 2015, vol. 20, # 8, p. 15206 - 15223
[4] Journal of the American Chemical Society, 1952, vol. 74, p. 3689
[5] Journal of the American Chemical Society, 1957, vol. 79, p. 4391,4393
[6] Patent: US2004/209865, 2004, A1,
[7] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 933 - 936
  • 4
  • [ 94740-40-6 ]
  • [ 79-14-1 ]
  • [ 68060-69-5 ]
  • [ 68-95-1 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1991, # 10, p. 1595 - 1600
  • 5
  • [ 79-14-1 ]
  • [ 95-55-6 ]
  • [ 77186-95-9 ]
Reference: [1] Patent: US2932649, 1958, ,
[2] Patent: US2877155, 1957, ,
[3] Patent: US2508324, 1946, ,
  • 6
  • [ 79-14-1 ]
  • [ 95-54-5 ]
  • [ 4856-97-7 ]
YieldReaction ConditionsOperation in experiment
89.1% With hydrogenchloride In water for 2 h; Reflux This compound was prepared based on a known methodwith some modification [19, 20]. Mixture of o-phenylenediamine (27 g, 0.25 mol) in 500 mL 4M HCl and glycolic acid (34.2 g, 0.45 mol) in 250 mL 4 M HCl stirred and heated under refluxfor 2 h. Then slowly cooled and resultant mixture was basified with aqueous sodium hydroxidesolution. The solid obtained, filtered, dried and re-crystallized with hot water (Scheme 1). (I:white to light brown powder, m.p. 171-174 oC, 89.1percent yield).
85% With hydrogenchloride In water at 100℃; for 4 h; At room temperature,10.0 g (92.6 mmol) of o-phenylenediamine and 20.0 g (263.0 mmol) of glycolic acid were placed in a 250 mL flask,Add 80 mL of 4 mol 1 / L hydrochloric acid and reflux at 100 ° C for 4 h.After completion of the reaction, the reaction solution was cooled to room temperature,Adjusted to pH 8.0 with potassium hydroxide and precipitated in a large amount. The solid was collected by filtration and recrystallized from water. Yield: 85.0percent.
85% With hydrogenchloride In water; N,N-dimethyl-formamide at 100℃; for 4 h; The o-phenylenediamine (10.0 g, 92.6 mmol)And glycolic acid (20.0 g, 263.0 mmol) were placed in 250 mL of eggplantFlask, add 80mL 4mol / L hydrochloric acid, 100 reflux 4h. After completion of the reaction, the reaction solution was cooled to room temperature and treated with hydrogenPotassium adjusted to pH 8.0, precipitate a large amount of solid, filter the solid, and recrystallize with water. The yield was 85percent.
81% at 130℃; for 3 h; General procedure: To a mixture of 1a–1c (10 mmol) with glycolic acid (2.28 g, 30 mmol) was added concentrated H3PO4(20 mL). The reaction mixture was refluxed at 130°C for 3 h, then quenched with 20percent NaOH. The respective solid product was collected by filtration. (1H-Benzoimidazole-2-yl)methanol (2a). White solid, yield 81percent, mp 169–171°C (177–179°C [18]). 1H NMR spectrum, δ, ppm: 4.69 s (2H, CH2), 5.69 s (1H, OH), 7.12–7.52 m (4H, ArH), 12.31 s (1H, NH).
73% With hydrogenchloride In water at 100℃; for 3 h; Step 1: ( lH-Benzo[d]imidazoI-2-yl)methanoiTo a stirred solution of O-phenylenediamine (5 g, 0.046 mol) in 4N HCI (50 mL) was added 2-hydroxyacetic acid (4.2 g, 0.0555 mol) and stirring was continued for 3 h at 100°C. The reaction mixture was cooled to room temperature, neutralized with satu rated sodium bicarbonate solution and the solid obtained was collected by filtration and dried to afford the title compound (3.5 g, 73percent).lNMR (400 MHz, DMSO-d6) : δ 12.28 (brs, 1H), 7.52-7.44 (m, 2H), 7.12 (d, J = 4.80 Hz, 2H), 5.66 (t, J = 6.0 Hz, 1H), 4.68 (d, J=5.2 Hz, 2H) .
73% With hydrogenchloride In water at 95℃; for 2 h; (1H-Benzimidazol-2-yl)methanol
To a mixture of benzene-1,2-diamine (5.0 g, 46.3 mmol) and glycolic acid (10.5 g, 138.0 mmol) was added 4N HCl (30 mL).
The reaction mixture was heated under reflux at 95° C. for 2 h, then cooled to 0° C. and neutralized with saturated aqueous NaOH.
The precipitated solid was isolated by filtration and dried in vacuo to afford the title compound (5 g, 73percent) as an off-white solid. δH (d6-DMSO) 12.20 (br s, 1H), 7.49-7.47 (dd, J 5.8, 3.2 Hz, 2H), 7.13-7.11 (dd, J 5.8, 3.2 Hz, 2H), 4.68 (s, 2H). LCMS (ES+) 149 (M+H)+.
65% With hydrogenchloride In water for 16 h; Reflux To a well stirred mixture of 1,2-phenylenediamine 17 (1 g, 9.25 mmol) in 6 M HCl (10 ml) was added 67percent w/v glycolic acid (6.30 ml, 55.48 mmol) dropwise, till the suspension was clear. After stirring for 10 min at room temperature, the reaction flask was plugged to a condenser and refluxed overnight. Reaction mixture was cooled and concentrated under overnight ventilation affording the HCl salt of the title compound as needle crystals. The crystals were washed with least amount of cold EtOH on a filter paper and dried in oven at 45 °C overnight. The dried crystals were dissolven in water and then precipitated with 1 M K2CO3 (20 ml) furnishing the title compound as a free base in crude mixture. After the effervescence was settled, the crude residue was extracted with EtOAc (2x), washed with brine and the organic solvent was removed in-vacuo.
The pure free base was obtained as white crystals (4.45 g). Yield: 65percent; mp: 165-167 °C; IR (KBr): 3257, 3061, 2931, 1617, 1485, 1440, 1347, 1270, 1048, 876, 746, 681; 1H NMR (300 MHz, DMSO-d6): δ 4.68 (d, J = 5.74 Hz, 2H), 5.63 (t, J = 5.74 Hz, 1H), 7.05-7.22 (m, 2H), 7.48 (dd, J = 3.42, 5.86 Hz, 2H), 12.26 (br s, 1H); MS (EI+) m/z: 148 [M+].
47% With hydrogenchloride In waterReflux General procedure: The mixture of appropriate 1,2-diaminobenzene derivatives (0.1 mol) and appropriate carboxylic acid derivatives (0.15 mol) in 100 ml 5N HCl were heated to reflux and stirred for 3-5 hours. After the reaction mixture was cooled to the room temperature and neutralized with sodium bicarbonate. The precipitate formed was filtered by suction filtration, washed with water and dried.
38% With hydrogenchloride In water for 4 h; Reflux General procedure: (1H-benzo[d]imidazol-2-yl)methanol was prepared by stirring o-phenylenediamine (1.3 g, 12mmol), and 85percent glycolic acid (2.74 g, 36 mmol, 300 molpercent), in 4 N HCl (40 mL), under reflux for 4 hours. Aftercooling to room temperature, the pH was adjusted to 7, with NaOH. The resulting crystals were filtered, washedwith water and dried in vacuo (0.67 g, 4.4 mmol, 38percent yield).

Reference: [1] Molecules, 2015, vol. 20, # 8, p. 15206 - 15223
[2] Bulletin of the Chemical Society of Ethiopia, 2014, vol. 28, # 3, p. 451 - 456
[3] Monatshefte fur Chemie, 2016, vol. 147, # 12, p. 2209 - 2220
[4] Patent: CN106905241, 2017, A, . Location in patent: Paragraph 0127-0129
[5] Patent: CN107118249, 2017, A, . Location in patent: Paragraph 0117; 0118; 0119
[6] Russian Journal of General Chemistry, 2017, vol. 87, # 12, p. 3006 - 3016
[7] Bulletin of the Korean Chemical Society, 2013, vol. 34, # 4, p. 1272 - 1274
[8] Patent: WO2014/169167, 2014, A1, . Location in patent: Page/Page column 60
[9] Patent: US2015/152065, 2015, A1, . Location in patent: Paragraph 0483
[10] CrystEngComm, 2011, vol. 13, # 3, p. 883 - 888
[11] Journal of Fluorescence, 2011, vol. 21, # 5, p. 2005 - 2013
[12] European Journal of Medicinal Chemistry, 2016, vol. 109, p. 157 - 172
[13] Journal of Pharmacy and Pharmacology, 2014, vol. 66, # 11, p. 1593 - 1605
[14] Journal of Medicinal Chemistry, 2015, vol. 58, # 11, p. 4713 - 4726
[15] Chemistry - An Asian Journal, 2018, vol. 13, # 17, p. 2458 - 2464
[16] Synthesis, 2005, # 7, p. 1069 - 1076
[17] Revue Roumaine de Chimie, 2016, vol. 61, # 1, p. 15 - 22
[18] Annales Pharmaceutiques Francaises, 2003, vol. 61, # 1, p. 57 - 61
[19] Journal of Medicinal Chemistry, 1997, vol. 40, # 26, p. 4199 - 4207
[20] Synthesis (Germany), 2015, vol. 47, # 13, p. 1913 - 1921
[21] Chemische Berichte, 1912, vol. 45, p. 3495
[22] Journal of the Chemical Society, 1928, p. 2395
[23] Indian Journal of Chemistry, Section A: Inorganic, Physical, Theoretical & Analytical, 1986, vol. 25, # 12, p. 1092 - 1096
[24] Journal of Medicinal Chemistry, 2009, vol. 52, # 5, p. 1345 - 1357
[25] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 933 - 936
[26] Phosphorus, Sulfur and Silicon and the Related Elements, 2013, vol. 188, # 11, p. 1564 - 1575
[27] Patent: WO2015/76801, 2015, A1, . Location in patent: Page/Page column 140
[28] European Journal of Medicinal Chemistry, 2016, vol. 122, p. 584 - 600
[29] European Journal of Medicinal Chemistry, 2016, vol. 124, p. 608 - 621
[30] Molecules, 2016, vol. 21, # 11,
[31] Patent: CN107698577, 2018, A, . Location in patent: Paragraph 0111; 0112; 0113; 0114
[32] MedChemComm, 2018, vol. 9, # 7, p. 1194 - 1205
  • 7
  • [ 79-14-1 ]
  • [ 108-45-2 ]
  • [ 4856-97-7 ]
Reference: [1] Journal de Chimie Physique et de Physico-Chimie Biologique, 1988, vol. 85, # 2, p. 309 - 314
  • 8
  • [ 79-14-1 ]
  • [ 98-86-2 ]
  • [ 2166-31-6 ]
YieldReaction ConditionsOperation in experiment
17.9%
Stage #1: at 110℃; for 2 h;
Stage #2: With ammonia In water at 40℃;
Stage #3: With hydrazine hydrate In water at 100℃; for 2 h;
Preparation of 6-Phenylpyridazin-3(2H)-one 5-3: (1197) (1198) A mixture of Cpd-5-1(1 g, 13.5 mmol) and 5-2 (4.88 g, 40.5 mmol) was heated at 110°C for 2h, cooled down to 40°C followed by addition of water (4.5 ml) and concentrated aqueous ammonia (1 ml). The reaction mixture was thereafter extracted with DCM, organic part was separated and the ammoniacal aqueous layer was treated with hydrazine hydrate (676 mg, 13.5mmol) followed by heating at 100°C for 2h, reaction mass cooled down to room temperature, precipitate formed was collected by filtration, residue dried under vaccum to afford 6-phenylpyridazin-3(2H)-one 5-3 (417 mg, 2.42 mmol, 17.9 percent) as an off-white solid. LC MS: ES+ 173.3
Reference: [1] Patent: WO2017/197051, 2017, A1, . Location in patent: Page/Page column 297-298
  • 9
  • [ 79-14-1 ]
  • [ 3460-18-2 ]
  • [ 24036-52-0 ]
Reference: [1] Patent: US5141935, 1992, A,
  • 10
  • [ 79-14-1 ]
  • [ 59681-66-2 ]
  • [ 380177-22-0 ]
YieldReaction ConditionsOperation in experiment
45% at 20 - 150℃; for 5 h; 4-chloro-N1-methylbenzene-1,2-diamine (15.0 g, 96 mmol) and glycolic acid (8.1 g, 106 mmol) were mixed together in a sealed tube. The mixture was heated at 150 C for 5 hours before it was cooled down to room temperature. The residue was purified by flash column chromatography (0-5percent MeOH in CH2CI2) to give the product (8.5 g, 45percent YIELD). H NMR (300 MHz, CDC13) 5 : 3.80 (s, 3 H), 4.86 (s, 2 H), 7.13-7. 22 (m, 2 H), 7.62-7. 64 (m, 1 H).
Reference: [1] Patent: WO2004/74270, 2004, A2, . Location in patent: Page 131
[2] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 4, p. 1724 - 1730
  • 11
  • [ 79-14-1 ]
  • [ 2439-85-2 ]
  • [ 13831-31-7 ]
  • [ 5493-24-3 ]
YieldReaction ConditionsOperation in experiment
80.6% With di(rhodium)tetracarbonyl dichloride; triphenylphosphine copper; toluene-4-sulfonic acid In 1,4-dioxane; acetonitrile at 100℃; for 8 h; At room temperature, 100 mmol of the compound of formula (I)150 mmol of the compound of formula (II)14 mmol of a catalyst (a mixture of 7 mmol of ruthenium tetracarbonyl diboride and 7 mmol of triphenylphosphine copper (Cu (PPh3) Br)160 mmol of acetoxyacetyl chloride and 25 mmol of acidic compound p-toluenesulfonic acid were added to an appropriate organic solvent (a mixture of acetonitrile and 1,4-dioxane in a volume ratio of 2: 1) and then heated to 100 ° C The reaction was stirred at this temperature for 8 hours;After completion of the reaction, the reaction system was filtered and the pH of the filtrate was adjusted to pH with a base, and then distilled under reduced pressure The silica gel column was eluted with an equal volume of a mixture of chloroform and ethyl acetate and distilled again under reduced pressure to give The compound of the above formula (III) having a melting point of 109 to 110 ° C has a yield of 80.6percent.
Reference: [1] Patent: CN106432049, 2017, A, . Location in patent: Paragraph 0048; 0049; 0050; 0051; 0052
  • 12
  • [ 79-14-1 ]
  • [ 367-31-7 ]
  • [ 39811-07-9 ]
Reference: [1] Molecules, 2015, vol. 20, # 8, p. 15206 - 15223
[2] MedChemComm, 2018, vol. 9, # 7, p. 1194 - 1205
  • 13
  • [ 79-14-1 ]
  • [ 1575-37-7 ]
  • [ 540516-28-7 ]
Reference: [1] Molecules, 2015, vol. 20, # 8, p. 15206 - 15223
  • 14
  • [ 79-14-1 ]
  • [ 67-63-0 ]
  • [ 623-61-0 ]
Reference: [1] Synthetic Communications, 1998, vol. 28, # 5, p. 903 - 912
[2] Journal of the American Chemical Society, 2014, vol. 136, # 16, p. 5900 - 5903
[3] Biomacromolecules, 2010, vol. 11, # 8, p. 1930 - 1939
[4] Zeitschrift fuer Physikalische Chemie, Stoechiometrie und Verwandtschaftslehre, 1925, vol. 118, p. 102
[5] Monatshefte fuer Chemie, 1936, vol. 68, p. 372
  • 15
  • [ 79-14-1 ]
  • [ 187737-37-7 ]
  • [ 623-61-0 ]
Reference: [1] Patent: US2265946, 1939, ,
  • 16
  • [ 77287-34-4 ]
  • [ 79-14-1 ]
  • [ 849585-22-4 ]
  • [ 2491-15-8 ]
  • [ 144-62-7 ]
  • [ 127-17-3 ]
  • [ 57-13-6 ]
YieldReaction ConditionsOperation in experiment
0.002 mg at 80℃; for 24 h; General procedure: To model the chemical environment on the outer side of thetubular structures, NH2CHO (200 μL) was mixed with thesodium silicate solution (2.0 mL) in the presence of preformedMSH [ZnCl2, FeCl2·4H2O, CuCl2·2H2O, Fe2(SO4)3·9H2O,and MgSO4] (2.0percent w/w) at 80 °C for 24 h. In two selectedcases [FeCl2 and Fe2(SO4)3·9H2O], NH2CHO (200 μL) wasmixed with the sodium silicate solution (2.0 mL) in the presence of selected growing MSH (starting from 2.0percent w/w ofthe corresponding salt’s pellet) at 80 °C for 24 h. For the innerenvironment, NH2CHO (200 μL) was mixed with distilledwater (2.0 mL) in the presence of selected MSH (2.0percent w/w) at80 °C for 24 h. The reaction of NH2CHO (10percent v/v) with thesodium silicate solution (pH 12) without MSH membranes wasalso analyzed under similar experimental conditions. Theproducts were analyzed by gas chromatography associatedwith mass spectrometry (GC-MS) after treatment with N,Nbis-trimethylsilyl trifluoroacetamide in pyridine (620 μL) at 60°C for 4 h in the presence of betulinol (CAS Registry Number473-98-3) as the internal standard (0.2 mg). Mass spectrometrywas performed by the following program: injection temperature280 °C, detector temperature 280 °C, gradient 100 °C for 2min, and 10 °C/min for 60 min. To identify the structure of theproducts, two strategies were followed. First, the spectra werecompared with commercially available electron mass spectrumlibraries such as NIST (Fison, Manchester, U.K.). Second, GCMSanalysis was repeated with standard compounds. Allproducts have been recognized with a similarity index (SI)greater than 98percent compared to that of the reference standards.The analysis was limited to products of ≥1 ng/mL, and theyield was calculated as micrograms of product per startingformamide. For further experimental details, see the SupportingInformation.
Reference: [1] Biochemistry, 2016, vol. 55, # 19, p. 2806 - 2811
  • 17
  • [ 77287-34-4 ]
  • [ 79-14-1 ]
  • [ 617-48-1 ]
  • [ 2491-15-8 ]
  • [ 110-15-6 ]
  • [ 144-62-7 ]
  • [ 57-13-6 ]
  • [ 18514-52-8 ]
YieldReaction ConditionsOperation in experiment
0.01 mg at 80℃; for 24 h; General procedure: To model the chemical environment on the outer side of thetubular structures, NH2CHO (200 μL) was mixed with thesodium silicate solution (2.0 mL) in the presence of preformedMSH [ZnCl2, FeCl2·4H2O, CuCl2·2H2O, Fe2(SO4)3·9H2O,and MgSO4] (2.0percent w/w) at 80 °C for 24 h. In two selectedcases [FeCl2 and Fe2(SO4)3·9H2O], NH2CHO (200 μL) wasmixed with the sodium silicate solution (2.0 mL) in the presence of selected growing MSH (starting from 2.0percent w/w ofthe corresponding salt’s pellet) at 80 °C for 24 h. For the innerenvironment, NH2CHO (200 μL) was mixed with distilledwater (2.0 mL) in the presence of selected MSH (2.0percent w/w) at80 °C for 24 h. The reaction of NH2CHO (10percent v/v) with thesodium silicate solution (pH 12) without MSH membranes wasalso analyzed under similar experimental conditions. Theproducts were analyzed by gas chromatography associatedwith mass spectrometry (GC-MS) after treatment with N,Nbis-trimethylsilyl trifluoroacetamide in pyridine (620 μL) at 60°C for 4 h in the presence of betulinol (CAS Registry Number473-98-3) as the internal standard (0.2 mg). Mass spectrometrywas performed by the following program: injection temperature280 °C, detector temperature 280 °C, gradient 100 °C for 2min, and 10 °C/min for 60 min. To identify the structure of theproducts, two strategies were followed. First, the spectra werecompared with commercially available electron mass spectrumlibraries such as NIST (Fison, Manchester, U.K.). Second, GCMSanalysis was repeated with standard compounds. Allproducts have been recognized with a similarity index (SI)greater than 98percent compared to that of the reference standards.The analysis was limited to products of ≥1 ng/mL, and theyield was calculated as micrograms of product per startingformamide. For further experimental details, see the SupportingInformation.
Reference: [1] Biochemistry, 2016, vol. 55, # 19, p. 2806 - 2811
  • 18
  • [ 79-14-1 ]
  • [ 71-36-3 ]
  • [ 7397-62-8 ]
YieldReaction ConditionsOperation in experiment
92% at 120℃; To a thermometer, condenser,1L four-neck flask trap successively added glycolic acid (70percent) 200 g580 g of n-butanol and acidic ion exchange resin pretreated 10 g (pH = 2.0), heated to 120 ,Adjust the system vacuum, so that the system to maintain a certain amount of return.Use the water separator to separate the water produced by the reaction.After tracking the amount of water to the theoretical amount, stop the reaction, cool to room temperature, filter, with a small amount of n-butanol washing acid resin.The resulting filtrate was recovered by decompression of n-butanol,Distillation gave 224 g of n-butylhydroxyacetate,Purity 99.5percent, yield 92percent.
Reference: [1] Patent: CN105130801, 2017, B, . Location in patent: Paragraph 0031; 0032; 0033; 0034; 0035; 0036; 0037-0049
[2] Journal of the Chemical Society of Pakistan, 2014, vol. 36, # 6, p. 1109 - 1113
[3] Journal of the American Pharmaceutical Association (1912-1977), 1941, vol. 30, p. 133[4] Chem.Abstr., 1941, p. 6235
[5] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 16, p. 259
  • 19
  • [ 79-14-1 ]
  • [ 71-36-3 ]
  • [ 502-97-6 ]
  • [ 7397-62-8 ]
Reference: [1] Asian Journal of Chemistry, 2013, vol. 25, # 15, p. 8447 - 8450
  • 20
  • [ 109-65-9 ]
  • [ 79-14-1 ]
  • [ 7397-62-8 ]
Reference: [1] Turkish Journal of Chemistry, 2010, vol. 34, # 2, p. 187 - 191
  • 21
  • [ 79-14-1 ]
  • [ 25561-30-2 ]
  • [ 354-38-1 ]
  • [ 33581-77-0 ]
  • [ 55982-15-5 ]
Reference: [1] Environmental Science and Technology, 1998, vol. 32, # 16, p. 2357 - 2370
  • 22
  • [ 67-56-1 ]
  • [ 131543-46-9 ]
  • [ 79-14-1 ]
  • [ 2517-44-4 ]
  • [ 96-35-5 ]
  • [ 51673-84-8 ]
YieldReaction ConditionsOperation in experiment
11% for 4 h; [0041] A 40percent aqueous glyoxal solution was metered at a rate of 0.17 mol/h into the top of a heatable 1 m column (diameter 29 mm) filled with spheres of diameter 5 mm of the catalyst KA-3 (Sud-Chemie). At the same time, gaseous methanol was metered in at the bottom of the column. During the entire reaction, the apparatus was operated under nitrogen as a protective gas. The column was heated. A mixture of water and methanol was collected at the top of the column. The bottom effluent of the column consisted of a mixture of 1,1,2,2-tetramethoxyethane, 2,2-dimethoxyacetaldehyde, methyl 2-hydroxyacetate, 2-hydroxyacetic acid and methanol. The apparatus was operated for 4 hours, and the bottom effluent was analyzed by gas chromatography. According to the analysis, there were 11 g (0.07 mol, 11percent) of 1,1,2,2-tetramethoxyethane.
Reference: [1] Patent: US2004/186304, 2004, A1, . Location in patent: Page 3
  • 23
  • [ 79-14-1 ]
  • [ 100-39-0 ]
  • [ 30379-58-9 ]
YieldReaction ConditionsOperation in experiment
97%
Stage #1: With caesium carbonate In methanol; water at 20℃; for 0.5 h;
Stage #2: at 20℃; for 24 h;
A suspension 2-hydoxyaceticacid 47 (70percent in H2O) (889 mg, 12.0 mmol) and Cs2CO3 (1955 mg, 6.00 mmol) in MeOH (22 mL)/H2O (4 mL) was stirred for 30 min at rt. After that the solvent was removed and the residue was dissolved in DMF (18 mL) cooled at 0°C and after 10 min benzylbromide (2155 mg, 12.6 mmol) was added and the reaction mixture was stirred at rt for 24 h. The reaction mixture was quenched with brine (20 mL) and the organic layer was extracted with ethyl acetate (3x 25 mL), washed with H2O (25 mL), brine (20 mL), dried over MgSO4 and concentrated in vacuo to give 1877 mg (97percent) of Benzyl 2-hydroxyacetate 48 as a colorless liquid.HPLC: 2.68 min (70percent).
94% With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 0℃; 10127] Glycolic acid (7.60 g, 0.10 mol) was dissolved in10 ml of acetonitrile, into which benzyl bromide (13.60 g,0.08 mol) was added and uniformly stirred. DBU (12.16 g,0.08 mol) was slowly added dropwise into the reaction liquid at 00 C. Afier that, the reaction liquid was stirred overnight at room temperature. The reaction liquid was poured into ice water, extracted with ethyl acetate, the combined resultant organic phase was washed with 1 M hydrochloric acid solution and saturated salt water successively, dried with anhydrous sodium sulfate and concentrated by rotary evaporation to give the compound as a yellow oil (12.50 g, 94percent).
94% With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 0 - 20℃; a. Preparation of benzyl glycolate (0150) Glycolic acid (7.60 g, 0.10 mol) was dissolved in 10 ml of acetonitrile, into which benzyl bromide (13.60 g, 0.08 mol) was added and uniformly stirred. DBU (12.16 g, 0.08 mol) was slowly added dropwise into the reaction liquid at 0° C. After that, the reaction liquid was stirred overnight at room temperature. The reaction liquid was poured into the ice water, extracted with ethyl acetate, the combined resultant organic phase was washed with 1M hydrochloric acid solution and saturated salt water successively, dried with anhydrous sodium sulfate and concentrated by rotary evaporation to give the compound as a yellow oil (12.50 g, 94percent).
69%
Stage #1: With sodium hydride In tetrahydrofuran at 0 - 20℃; for 1 h;
Stage #2: With potassium iodide In N,N-dimethyl-formamide at 100℃; for 24 h;
NaH (6.31 g, 158 mmol) was suspended in dry THF (500 ml) and cooled to 0° C. 2-hydroxyacetic acid (12 g, 158 mmol) was added portion wise, and the mixture was stirred at RT for 1 hour. The solvent was removed, and the residue was suspended in DMF (500 ml); KI (2.488 g, 14.99 mmol) and benzyl bromide (18.77 ml, 158 mmol) were added; and the mixture was heated to 100° C. for 24 hours. The solvent was removed, and the crude was portioned between EtOAc (600 ml) and water (200 ml). The organic phase was washed with brine and dried over Na2SO4. The solvent was removed and the crude was purified by flash chromatography on silica gel (petroleum ether/EtOAc 80/20). Benzyl 2-hydroxyacetate was obtained (18.089 g, 69percent yield).
63% With 1,8-diazabicyclo[5.4.0]undec-7-ene In tolueneReflux A mixture of 2-hydroxyacetic acid (5.0 g, 65.7 mmol), l,8-diazabicyclo[5.4.0]undec-7- ene (9.9 g, 65.7 mmol) and benzyl bromide (13.0 g, 78.9.mmol) in toluene (150 mL) was refluxed overnight. The reaction mixture was worked up and the crude product was purified by silica gel flash column chromatography (eluent 20-50percent ethyl acetate in hexane) to give tert- butyl benzyl 2-hydroxyacetate (6.9g, yield 63percent) as a colorless oil. *H NMR (400 MHz, CDC13): δ 2.60 (t, / = 5.6 Hz, 1H), 4.19 (d, / =5.6 Hz, 2H), 5.21 (s, 2H), 7.35-7.37 (m, 5H).
59%
Stage #1: With sodium hydride In tetrahydrofuran at 0 - 20℃; for 1 h;
Stage #2: With potassium iodide In N,N-dimethyl-formamide at 100℃; for 24 h;
NaH (6.31 g, 158 mmol) was suspended in dry THF (500 ml) and cooled to 0°C. 2-hydroxyacetic acid (12 g, 158 mmol) was added portion wise and the mixture was stirred at RT for lh. The solvent was removed and the residue was suspended in DMF (500 ml); KI (2.488 g, 14.99 mmol) and benzyl bromide (18.77 ml, 158 mmol) were added and the mixture was heated to 100°C for 24h. The solvent was removed and the crude was portioned between EtOAc (600 ml) and water (200 ml). The organic phase was washed with brine and dried over Na2S04. The solvent was removed and the crude was purified by flash chromatography on silica gel (petroleum ether/EtOAc 80/20). Benzyl 2-hydroxyacetate was obtained (18.089 g, 69percent yield).
54% With Ki; NaH In tetrahydrofuran; N,N-dimethyl-formamide; mineral oil B.
Alternatively, to a cold (0° C.) suspension of NaH (3.8 g of a 60percent weight dispersion in mineral oil, 95.0 mmol) in THF (50 mL) was added a solution of glycolic acid (7.2 g, 95 mmol) in THF (50 mL) dropwise via cannula.
The resulting solution was warmed to 25° C. and concentrated in vacuo.
The resulting salt was suspended in DMF (100 mL) and treated with KI (1.57 g, 0.1 eq) and benzyl bromide (12.3 mL, 1.1 eq).
The mixture was heated at 100° C. for 23 hours under argon and the DMF was evaporated.
The residue was dissolved in ether and washed with water, saturated Na2 S2 O3, and brine, and dried over MgSO4.
Distillation afforded benzyl glycolate (8.5 g, 54percent) as a colorless oil, b.p. 85-87° C. (0.5 Torr).
54% With Ki; NaH In tetrahydrofuran; N,N-dimethyl-formamide; mineral oil B.
Alternatively, to a cold (0° C.) suspension of NaH (3.8 g of a 60percent weight dispersion in mineral oil, 95.0 mmol) in THF (50 mL) was added a solution of glycolic acid (7.2 g, 95 mmol) in THF (50 mL) dropwise via cannula.
The resulting solution was warmed to 25° C. and concentrated in vacuo.
The resulting salt was suspended in DMF (100 mL) and treated with KI (1.57 g, 0.1 eq) and benzyl bromide (12.3 mL, 1.1 eq).
The mixture was heated at 100° C. for 23 hours under argon and the DMF was evaporated.
The residue was dissolved in ether and washed with water, saturated Na2 S2 O3, and brine, and dried over MgSO4.
Distillation afforded benzyl glycolate (8.5 g, 54percent) as a colorless oil, b.p. 85°-87° C. (0.5 Torr).

Reference: [1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 16, p. 4903 - 4909
[2] Journal of Organic Chemistry, 2000, vol. 65, # 22, p. 7667 - 7675
[3] Patent: US2016/340365, 2016, A1, . Location in patent: Paragraph 0126; 0127
[4] Patent: US2016/297784, 2016, A1, . Location in patent: Paragraph 0150; 0151
[5] Journal of the American Chemical Society, 2010, vol. 132, # 31, p. 10920 - 10934
[6] Journal of the American Chemical Society, 1993, vol. 115, # 21, p. 9774 - 9788
[7] Journal of Organic Chemistry, 1988, vol. 53, # 18, p. 4282 - 4295
[8] Patent: US2013/79313, 2013, A1, . Location in patent: Paragraph 0714
[9] Journal of Medicinal Chemistry, 2009, vol. 52, # 10, p. 3348 - 3353
[10] Chemical Biology and Drug Design, 2016, p. 542 - 555
[11] Patent: WO2017/30814, 2017, A1, . Location in patent: Paragraph 00286
[12] Patent: WO2013/45280, 2013, A1, . Location in patent: Page/Page column 134
[13] Patent: US6013792, 2000, A,
[14] Patent: US5773428, 1998, A,
[15] Journal of the American Chemical Society, 2010, vol. 132, # 6, p. 1766 - 1767
[16] Journal of Medicinal Chemistry, 1992, vol. 35, # 10, p. 1828 - 1839
[17] Helvetica Chimica Acta, 1991, vol. 74, # 8, p. 1697 - 1706
[18] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 11, p. 3217 - 3220
[19] Journal of Chemical Research, 2010, # 10, p. 562 - 564
[20] Journal of Materials Chemistry, 2011, vol. 21, # 39, p. 15305 - 15315
  • 24
  • [ 79-14-1 ]
  • [ 100-51-6 ]
  • [ 30379-58-9 ]
YieldReaction ConditionsOperation in experiment
80%
Stage #1: With toluene-4-sulfonic acid In benzene for 0.5 h; Reflux
Stage #2: Reflux
General procedure: Benzyl alcohol (1.2 equiv) and p-toluenesulfonic acid (0.1 equiv) were taken in benzene and refluxed for 0.5 h, then compounds 10(A-G) (1 equiv) was added, and continuously reflexed until the completion of the reaction (monitored by TLC: petroleum ether/ethyl acetate, 8:1; typically 4 h). The reaction mixture was washed with saturated NaHCO3 solution, water and brine. The organic layer was dried over anhydrous sodium sulfate, filtered and evaporated under reduced pressure. Purification by flash column chromatography gave the desired compounds 11(A-G) as colorless oil.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 1, p. 482 - 484
[2] Synthesis, 2005, # 20, p. 3555 - 3564
  • 25
  • [ 79-14-1 ]
  • [ 100-44-7 ]
  • [ 30379-58-9 ]
Reference: [1] Angewandte Chemie, 1986, vol. 98, # 3, p. 264 - 265
[2] Bulletin de la Societe Chimique de France, 1970, p. 4018 - 4023
  • 26
  • [ 79-14-1 ]
  • [ 908094-04-2 ]
  • [ 30379-58-9 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 19, p. 2691 - 2698
  • 27
  • [ 79-14-1 ]
  • [ 824-94-2 ]
  • [ 88920-24-5 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 17, p. 3472 - 3485
  • 28
  • [ 79-14-1 ]
  • [ 58479-61-1 ]
  • [ 76271-74-4 ]
YieldReaction ConditionsOperation in experiment
90.3% at 20℃; 0.8 mol of glycolic acid (Compound 5) was dissolved in 1 L of pyridine.One mole of tert-butyldiphenylchlorosilane (TBDPSCl) was added and allowed to react at room temperature overnight. Vacuum removal of pyridine,600 mL of distilled water was added and the mixture was extracted three times with 600 mL each of ethyl acetate.The organic layer was neutralized with 5percent aqueous HCl, washed with 500 ml of brine, dried over Na2SO4, filtered and concentrated.The residue was purified on a silica gel column using a gradient of ethyl acetate/petroleum ether (1/2) to give a colorless oil, yielding 227 g of compound 5-1.The yield was 90.3percent.
Reference: [1] Patent: CN107854694, 2018, A, . Location in patent: Paragraph 0032; 0035-0037
[2] Journal of the American Chemical Society, 2004, vol. 126, # 32, p. 10162 - 10173
[3] Organic and Biomolecular Chemistry, 2012, vol. 10, # 17, p. 3472 - 3485
  • 29
  • [ 79-14-1 ]
  • [ 2582-30-1 ]
  • [ 63870-39-3 ]
YieldReaction ConditionsOperation in experiment
85% at 25 - 108℃; for 22.1 h; [439] A mixture of glycolic acid (26.2 g, 345 mmol) and water (10 mL) was treated with aminoguanidine bicarbonate (23.5 g, 172 mmol) in small portions over a period of 0.1 hr. The resultant mixture was gently heated to maintain an internal temp of 25 °C during the addition. The mixture was then treated with slow addition of cone, nitric acid (1.0 mL), followed by heating to an internal temperature of 104-108 °C over 22 hr. The heating was then discontinued and the solution allowed to cool with stirring. The resultant slurry was cooled down 10 °C, stirred over 2 hr, filtered, and rinsed with EtOH. The solids were dried overnight in a vacuum to provide the product 88a as a glycolic acid salt (29.5 g, 85percent). MS calcd: (M+H)+ = 115. MS found: (M+H)+ = 115.
75%
Stage #1: at 20 - 25℃; for 0.166667 h;
Stage #2: With nitric acid In water at 104 - 108℃; for 22 h;
Glycolic acid (1 L, 70percent in water, 11.51 mol) was added to a 5 L flask. To the solution was slowly added aminoguanidine bicarbonate (783.33 g, 5.755 mol) in portions to control significant bubbling. As solids are added, the solution cools due to endothermic dissolution. EPO <DP n="56"/>The solution was gently heated to maintain an internal temp of 25 °C during addition. Ten minutes after complete addition of aminoguanidine bicarbonate, cone. Nitric acid (6.8 ml_) was carefully added. The solution was heated to an internal temperature of 104-108 0C (mild reflux) for 22 h. The heating was discontinued and the solution allowed to cool, with stirring. At an internal temp of aboutδi °C, solids began to crystallize. After the internal temperature was just below 80 0C, ethanol (absolute, 375 mL) was slowly added to the mixture. After the internal temp had cooled to aboutδδ 0C1 the cooling was sped up by the use of an ice/water bath. After cooling below rt, the solution became very thick but remained stirrable at all times. The slurry was stirred for 2h at T<10 0C, then filtered and the solids rinsed with ethanol (900 mL cold, then 250 mL rt). The solids were dried overnight in a vacuum oven (about25 mmHg, 45-50 0C) to provide 815.80 g (75percent) of (5-amino-1H-1 ,2,4-triazol-3-yl)methanol as the glycolate salt. 1H (300 MHz, de-DMSO): 3.90 (s, 2), 4.24 (s, 2).
70.5%
Stage #1: With octanol In water
Stage #2: With nitric acid In water at 5℃; for 40.7 h; Heating / reflux
The title compound was prepared by a slight modification of a reported procedure (Allen, C. F. H. J. ORG. CHEM, 1959, 24,793) : A 5-L 3-necked flask was charged with aminoguanidine bicarbonate (275.6 g, 2.025 mol) and octyl alcohol (5.5 mL, to control foaming). To the mixture was added 70percent aqueous glycolic acid (440 g, 4.05 mol, 2 equiv) gradually, during which time evolution of CO2 was observed. When foaming and gas evolution had ceased, concentrated nitric acid (2.2 mL) was added so that it wet the sides of the flask above the liquid. The reaction mixture was refluxed for 40 h, then cooled to 5 C and maintained at this temperature for 40 min. The resulting slurry was filtered, and the solid washed with EtOH and dried in vacuo at 30 C to give the crude product as a white solid (313 g). The mother liquor was stirred at 0 C (ice bath) for 1 h and filtered, affording a second batch of material (51 g). These two batches were combined and recrystallized from hot ETOH, affording 271.5 g, (70.5 percent). 'H NMR (300 MHz, DMSO-d6) 5 3.89 (2H), 4.24 (2H), 5.58 (2H). LC-MS (APCI) calcd for C3H6N40 : 114.05 ; found (M+H+) : 115.1 m/z
70.5%
Stage #1: With octanol In water
Stage #2: With nitric acid In water at 5℃; for 40.6667 h; Heating / reflux
The title compound was prepared by a slight modification of a reported procedure (Allen, C. F. H. J. Org. Chem, 1959, 24, 793): A 5-L 3-necked flask was charged with aminoguanidine bicarbonate (275.6 g, 2.025 mol) and octyl alcohol (5.5 mL, to control foaming). To the mixture was added 70percent aqueous glycolic acid (440 g, 4.05 mol, 2 equiv) gradually, during which time evolution of CO2 was observed. When foaming and gas evolution had ceased, concentrated nitric acid (2.2 mL) was added so that it wet the sides of the flask above the liquid. The reaction mixture was refluxed for 40 h, then cooled to 5° C. and maintained at this temperature for 40 min. The resulting slurry was filtered, and the solid washed with EtOH and dried in vacuo at 30° C. to give the crude product as a white solid (313 g). The mother liquor was stirred at 0° C. (ice bath) for 1 h and filtered, affording a second batch of material (51 g). These two batches were combined and recrystallized from hot EtOH, affording 271.5 g, (70.5percent). 1H NMR (300 MHz, DMSO-d6) δ 3.89 (2H), 4.24 (2H), 5.58 (2H). LC-MS (APCI) calcd for C3H6N4O: 114.05; found (M+H+): 115.1 m/z.

Reference: [1] Patent: WO2012/83105, 2012, A1, . Location in patent: Page/Page column 101
[2] Patent: WO2007/23381, 2007, A1, . Location in patent: Page/Page column 54-55
[3] Patent: WO2004/74270, 2004, A2, . Location in patent: Page 300
[4] Patent: US2005/176701, 2005, A1, . Location in patent: Page/Page column 144
  • 30
  • [ 452-58-4 ]
  • [ 79-14-1 ]
  • [ 97640-15-8 ]
Reference: [1] Patent: WO2006/50976, 2006, A1, . Location in patent: Page/Page column 31
  • 31
  • [ 38875-53-5 ]
  • [ 79-14-1 ]
  • [ 172648-19-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2000, vol. 43, # 16, p. 3052 - 3066
  • 32
  • [ 79-14-1 ]
  • [ 41575-87-5 ]
  • [ 95734-82-0 ]
Reference: [1] Chemistry Letters, 1986, p. 429 - 432
  • 33
  • [ 79-14-1 ]
  • [ 63700-88-9 ]
  • [ 25289-18-3 ]
  • [ 95734-82-0 ]
Reference: [1] Chemistry Letters, 1986, p. 429 - 432
Same Skeleton Products
Historical Records

Similar Product of
[ 79-14-1 ]

Chemical Structure| 111389-68-5

A1267814[ 111389-68-5 ]

Glycolic Acid-13C2

Reason: Stable Isotope

Related Functional Groups of
[ 79-14-1 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 2836-32-0

[ 2836-32-0 ]

Sodium glycolate

Similarity: 0.92

Chemical Structure| 6153-56-6

[ 6153-56-6 ]

Oxalic acid dihydrate

Similarity: 0.85

Chemical Structure| 144-62-7

[ 144-62-7 ]

Oxalic acid

Similarity: 0.85

Chemical Structure| 1113-38-8

[ 1113-38-8 ]

Ammonium oxalate

Similarity: 0.79

Chemical Structure| 15750-47-7

[ 15750-47-7 ]

Cerium(III) oxalate xhydrate

Similarity: 0.79

Alcohols

Chemical Structure| 2836-32-0

[ 2836-32-0 ]

Sodium glycolate

Similarity: 0.92

Chemical Structure| 96-35-5

[ 96-35-5 ]

Methyl 2-hydroxyacetate

Similarity: 0.69

Chemical Structure| 79-33-4

[ 79-33-4 ]

(S)-2-Hydroxypropanoic acid

Similarity: 0.65

Chemical Structure| 867-56-1

[ 867-56-1 ]

Sodium (S)-2-hydroxypropanoate

Similarity: 0.61

Chemical Structure| 623-50-7

[ 623-50-7 ]

Ethyl 2-hydroxyacetate

Similarity: 0.61

Carboxylic Acids

Chemical Structure| 144-62-7

[ 144-62-7 ]

Oxalic acid

Similarity: 0.85

Chemical Structure| 563-96-2

[ 563-96-2 ]

2,2-Dihydroxyacetic acid

Similarity: 0.77

Chemical Structure| 298-12-4

[ 298-12-4 ]

2-Oxoacetic acid

Similarity: 0.77

Chemical Structure| 625-45-6

[ 625-45-6 ]

2-Methoxyacetic acid

Similarity: 0.73

Chemical Structure| 110-99-6

[ 110-99-6 ]

2,2'-Oxydiacetic acid

Similarity: 0.69